Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goal-directed fluid removal with furosemide in ICU patients with fluid overload
NL-OMON58862Phase 4Recruiting
- Sponsor
- Capital Region of Denmark
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypervolemia comparing Furosemide with Placebo (2 arms). Primary endpoint: Days alive and out of hospital at day 90. Started Aug 2023; status: recruiting.
02
Drugs
furosemide
03
Conditions
hypervolemia
Beyond the preview
Go deeper on NL-OMON58862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58862.